Global Lung Cancer Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Lung Cancer Therapy
    1.2 Classification of Lung Cancer Therapy by Type
        1.2.1 Overview: Global Lung Cancer Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Lung Cancer Therapy Revenue Market Share by Type in 2020
        1.2.3 Radiation Therapy
        1.2.4 Chemotherapy
        1.2.5 Targeted Therapies
        1.2.6 Immunotherapy
    1.3 Global Lung Cancer Therapy Market by Application
        1.3.1 Overview: Global Lung Cancer Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Global Lung Cancer Therapy Market Size & Forecast
    1.5 Global Lung Cancer Therapy Market Size and Forecast by Region
        1.5.1 Global Lung Cancer Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Lung Cancer Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Lung Cancer Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Lung Cancer Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Lung Cancer Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Lung Cancer Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Lung Cancer Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Lung Cancer Therapy Market Drivers
        1.6.2 Lung Cancer Therapy Market Restraints
        1.6.3 Lung Cancer Therapy Trends Analysis
2 Company Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline Lung Cancer Therapy Product and Solutions
        2.1.4 GlaxoSmithKline Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 GlaxoSmithKline Recent Developments and Future Plans
    2.2 Menarini
        2.2.1 Menarini Details
        2.2.2 Menarini Major Business
        2.2.3 Menarini Lung Cancer Therapy Product and Solutions
        2.2.4 Menarini Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Menarini Recent Developments and Future Plans
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Lung Cancer Therapy Product and Solutions
        2.3.4 Pfizer Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Pfizer Recent Developments and Future Plans
    2.4 Roche
        2.4.1 Roche Details
        2.4.2 Roche Major Business
        2.4.3 Roche Lung Cancer Therapy Product and Solutions
        2.4.4 Roche Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Roche Recent Developments and Future Plans
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Lung Cancer Therapy Product and Solutions
        2.5.4 Merck Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Merck Recent Developments and Future Plans
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Lung Cancer Therapy Product and Solutions
        2.6.4 AstraZeneca Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 AstraZeneca Recent Developments and Future Plans
    2.7 Sanofi-Aventis
        2.7.1 Sanofi-Aventis Details
        2.7.2 Sanofi-Aventis Major Business
        2.7.3 Sanofi-Aventis Lung Cancer Therapy Product and Solutions
        2.7.4 Sanofi-Aventis Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Sanofi-Aventis Recent Developments and Future Plans
    2.8 Eli Lilly and Company
        2.8.1 Eli Lilly and Company Details
        2.8.2 Eli Lilly and Company Major Business
        2.8.3 Eli Lilly and Company Lung Cancer Therapy Product and Solutions
        2.8.4 Eli Lilly and Company Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Eli Lilly and Company Recent Developments and Future Plans
    2.9 Abbott
        2.9.1 Abbott Details
        2.9.2 Abbott Major Business
        2.9.3 Abbott Lung Cancer Therapy Product and Solutions
        2.9.4 Abbott Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Abbott Recent Developments and Future Plans
    2.10 Akebia Therapeutics 
        2.10.1 Akebia Therapeutics Details
        2.10.2 Akebia Therapeutics Major Business
        2.10.3 Akebia Therapeutics Lung Cancer Therapy Product and Solutions
        2.10.4 Akebia Therapeutics Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Akebia Therapeutics Recent Developments and Future Plans
    2.11 Agennix AG
        2.11.1 Agennix AG Details
        2.11.2 Agennix AG Major Business
        2.11.3 Agennix AG Lung Cancer Therapy Product and Solutions
        2.11.4 Agennix AG Lung Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Agennix AG Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Lung Cancer Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Lung Cancer Therapy Players Market Share
        3.2.2 Top 10 Lung Cancer Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Lung Cancer Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Lung Cancer Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Lung Cancer Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Lung Cancer Therapy Revenue Market Share by Application (2016-2021)
    5.2 Lung Cancer Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Lung Cancer Therapy Revenue by Type (2016-2026)
    6.2 North America Lung Cancer Therapy Revenue by Application (2016-2026)
    6.3 North America Lung Cancer Therapy Market Size by Country
        6.3.1 North America Lung Cancer Therapy Revenue by Country (2016-2026)
        6.3.2 United States Lung Cancer Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Lung Cancer Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Lung Cancer Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Lung Cancer Therapy Revenue by Type (2016-2026)
    7.2 Europe Lung Cancer Therapy Revenue by Application (2016-2026)
    7.3 Europe Lung Cancer Therapy Market Size by Country
        7.3.1 Europe Lung Cancer Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Lung Cancer Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Lung Cancer Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Lung Cancer Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Lung Cancer Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Lung Cancer Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Lung Cancer Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Lung Cancer Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Lung Cancer Therapy Market Size by Region
        8.3.1 Asia-Pacific Lung Cancer Therapy Revenue by Region (2016-2026)
        8.3.2 China Lung Cancer Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Lung Cancer Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Lung Cancer Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Lung Cancer Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Lung Cancer Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Lung Cancer Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Lung Cancer Therapy Revenue by Type (2016-2026)
    9.2 South America Lung Cancer Therapy Revenue by Application (2016-2026)
    9.3 South America Lung Cancer Therapy Market Size by Country
        9.3.1 South America Lung Cancer Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Lung Cancer Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Lung Cancer Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Lung Cancer Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Lung Cancer Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Lung Cancer Therapy Market Size by Country
        10.3.1 Middle East & Africa Lung Cancer Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Lung Cancer Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Lung Cancer Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Lung Cancer Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer